Tango Therapeutics Inc.

NASDAQ: TNGX · Real-Time Price · USD
6.79
-0.13 (-1.88%)
At close: Aug 15, 2025, 3:59 PM
6.77
-0.29%
After-hours: Aug 15, 2025, 04:59 PM EDT

Tango Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
69.53M 66.39M 59.97M 142.75M
Short-Term Investments
188.39M 270.5M 306.17M 342.51M
Long-Term Investments
n/a n/a 3.42M 1.71M
Other Long-Term Assets
2.57M 2.61M 3.43M 19K
Receivables
n/a n/a 2M 2M
Inventory
n/a n/a 567K 567K
Other Current Assets
8.43M 9.65M 7.14M 567K
Total Current Assets
266.34M 346.54M 375.27M 492.34M
Property-Plant & Equipment
47.58M 53.42M 57.77M 6.09M
Goodwill & Intangibles
n/a n/a -18.46M n/a
Total Long-Term Assets
50.15M 56.03M 61.2M 7.82M
Total Assets
316.49M 402.57M 436.47M 500.15M
Account Payables
1.6M 2.79M 4.45M 3.23M
Deferred Revenue
17.62M 25.67M 31.79M 26.02M
Short-Term Debt
n/a n/a 1.77M 1.5M
Other Current Liabilities
1.74M 7.49M 9.99M 4.7M
Total Current Liabilities
38.17M 45.94M 55.55M 40.69M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
78.81M 103.52M 131.45M 114.72M
Total Liabilities
116.97M 149.46M 186.99M 155.41M
Total Debt
36.49M 38.92M 41.13M 1.5M
Common Stock
108K 102K 88K 88K
Retained Earnings
-501.56M -371.26M -269.51M -161.34M
Comprehensive Income
336K 186K -3.71M -765K
Shareholders Equity
199.52M 253.11M 249.48M 344.75M
Total Investments
188.39M 270.5M 306.17M 342.51M